Discovery
Helping you to achieve key decision milestones through deep scientific insights, innovation and collaboration.
Learn MorePreclinical
Enabling you to successfully develop and de-risk your preclinical candidates for a smooth transition to the clinic.
Learn MoreDigital
Empowering your drug discovery and development with integrated data services, machine learning and generative AI.
Learn MoreResearch phases
Supporting you with integrated, tailored solutions at every step of your drug discovery and development journey.
Nuvisan is the unique CRO/CDMO with extensive pharma experience and industry-leading scientific expertise, providing highest-quality end-to-end solutions. From enabling target understanding to helping get innovative medicines to the patients who need them, we provide support that streamlines and accelerates drug discovery and development.
Our science
News and events
Nuvisan receives US$25 million grant to advance novel non-hormonal contraceptive drug discovery
The new three-year grant from the Gates Foundation builds on a successful program, delivered over the past three years. It is intended to further expand the pipeline of non-hormonal contraceptive candidates, an area of significant unmet need in global health.
Learn More about Nuvisan receives US$25 million grant to advance novel non-hormonal contraceptive drug discovery















